Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ilaria Pansini
Observed name:
I. Pansini
Institutions:
Università Cattolica del Sacro Cuore,
Agostino Gemelli University Polyclinic,
Istituti di Ricovero e Cura a Carattere Scientifico,
IRCCS Humanitas Research Hospital
Observed institutions:
Università Cattolica del Sacro Cuore,
Agostino Gemelli University Polyclinic,
Istituti di Ricovero e Cura a Carattere Scientifico,
IRCCS Humanitas Research Hospital
ORCID:
0009-0008-8929-0361
Observed ORCID:
0009-0008-8929-0361
OpenAlex ID:
A5042739217
The CD4/CD8 ratio of infused CD19‐CAR‐T is a prognostic factor for efficacy and toxicity
2023
·
Eugenio Galli
, Silvia Bellesi
, et al.
·
British Journal of Haematology
·
76
PDF
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti‐CD19 CAR‐T cells
2022
·
Eugenio Galli
, Federica Sorà
, et al.
·
British Journal of Haematology
·
62
PDF
Hematopoiesis and immune reconstitution after CD19 directed chimeric antigen receptor T‐cells (CAR‐T): A comprehensive review on incidence, risk factors and current management
2023
·
Eugenio Galli
, Alberto Fresa
, et al.
·
European Journal Of Haematology
·
24
PDF
Predicting therapy‐related myeloid neoplasms after CAR‐T with the Clonal Haematopoiesis Risk Score (CHRS)
2024
·
Eugenio Galli
, Monica Rossi
, et al.
·
British Journal of Haematology
·
12
PDF
Unlocking Predictive Power: Quantitative Assessment of CAR-T Expansion with Digital Droplet Polymerase Chain Reaction (ddPCR)
2024
·
Eugenio Galli
, Marcello Viscovo
, et al.
·
International Journal of Molecular Sciences
·
11
PDF
Baseline Tumor Burden Assessed With AI‐Guided PET/CT Total Metabolic Tumor Volume (TMTV) and LDH Levels Predict Efficacy of CAR‐T in Aggressive B‐Cell Lymphoma
2024
·
Eugenio Galli
, Andrea Guarneri
, et al.
·
Hematological Oncology
·
10
PDF
High Levels of Circulating Granulocytic Myeloid-Derived Suppressor Cells (G-MDSCs) Predict Failure of CD19-Targeting CAR-T Cell Therapy
2023
·
Eugenio Galli
, Alessandra Battaglia
, et al.
·
Blood
·
7
Routine prophylaxis with levetiracetam offers no benefit in CD19 CAR-T for LBCL: a multicenter propensity-matched study
2025
·
Eugenio Galli
, Roberta Di Blasi
, et al.
·
Blood Advances
·
6
Frail is not fail: Limited impact of comorbidities on non‐relapse mortality and safety in patients with LBCL treated with CAR ‐T
2025
·
Eugenio Galli
, Roberta Di Blasi
, et al.
·
British Journal of Haematology
·
5
PDF
Neuronal injury biomarkers GFAP and neurofilament light chains (NfL) are associated with neurotoxicity and endothelial dysfunction in adult patients treated with antiCD19 CART cells
2026
·
Eugenio Galli
, Anna Modoni
, et al.
·
Clinical and Experimental Medicine
·
3
Impact of SARS-CoV-2 vaccination and passive prophylaxis with tixagevimab/cilgavimab on CAR-T patients: a three-year regional experience from the Italian covid pandemic
2023
·
Eugenio Galli
, Alice Di Rocco
, et al.
·
Bone Marrow Transplantation
·
3
InflaMix Predicts Severe CRS , ICU Admission, and Progression‐Free Survival After CAR ‐T Therapy in LBCL
2026
·
Eugenio Galli
, Daniele Mannina
, et al.
·
European Journal Of Haematology
·
2
PDF
Blood-Brain Barrier and Neuronal Damage during Icans in Patients Treated with Anti-CD19 CAR-T Cells
2023
·
Eugenio Galli
, Anna Modoni
, et al.
·
Blood
·
2
PDF
Tracking Inflammation in CAR-T Therapy: The Emerging Role of Serum Amyloid A (SAA)
2025
·
Ilaria Pansini
, Eugenio Galli
, et al.
·
Cancers
·
1
PDF
Serum Amyloid-a (SAA) Is an Optimal Acute Phase Protein for Cytokine Release Syndrome in CAR-T Patients Exposed to Tocilizumab
2024
·
Eugenio Galli
, Ilaria Pansini
, et al.
·
Blood
·
1
Co065 | Thrombotic Risk Is Not Uniform Across Apheresis Settings: Insights From Car-t Lymphocytapheresis and Autologous Stem Cell Collection
2026
·
Ilaria Pansini
·
Bleeding Thrombosis and Vascular Biology
Independent validation of the International Metabolic Prognostic Index (CAR‐IMPI) in patients with aggressive diffuse large B‐cell lymphoma treated with CAR‐T
2026
·
Eugenio Galli
, Andrea Guarneri
, et al.
·
British Journal of Haematology
Early deterioration and subsequent recovery of nursing complexity after CAR-T therapy: a prospective score-based analysis
2026
·
Eugenio Galli
, Ilaria Pansini
, et al.
·
Bone Marrow Transplantation
Po38 | Pericatheter and Systemic Thrombosis During Car-t Lymphocytapheresis: Incidence and Clinical Correlates
2026
·
Ilaria Pansini
·
DOAJ (DOAJ: Directory of Open Access Journals)
Validation of a New Scoring System for Treatment Failure in CML Patients on Tyrosine Kinase Inhibitors in a real world setting
2026
·
Andrea Mattozzi
, Eugenio Galli
, et al.
·
Mediterranean Journal of Hematology and Infectious Diseases
PDF
Aberrant lymphocytes are associated with increased inflammatory complications following CAR-T infusion
2025
·
John Marra
, Gina Zini
, et al.
·
Blood
PDF
Author response for "Baseline Tumor Burden Assessed With AI‐Guided PET/CT Total Metabolic Tumor Volume (TMTV) and LDH Levels Predict Efficacy of CAR‐T in Aggressive B‐Cell Lymphoma"
2024
·
Eugenio Galli
, Andrea Guarneri
, et al.
·
Publons reviews and discussion
P1380: the Composition of Infused Cd19-car-t Product Impacts on Efficacy
2023
·
Silvia Bellesi
, Eugenio Galli
, et al.
·
HemaSphere
Limited BA.5 neutralization by pre-exposure prophylaxis with tixagevimab/cilgavimab in CAR-T treated people
2023
·
Alessandra Vergori
, Giulia Matusali
, et al.
·
Research Square
PDF
Show more works
View as search
Works count:
26
Citation count:
225
H-index:
7
I10-index:
6
Year
Topic
Type